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Abstract 
 
The Complior device (Alam Medical, France) was used in epidemiological studies 
which established pulse wave velocity (PWV) as cardiovascular risk marker. Central 
pressure is related but complementary to PWV and also associated to cardiovascular 
outcomes. The new Complior Analyse measures both PWV and central BP during 
the same acquisition. 
The aim of this study was to compare PWV values from Complior Analyse with the 
previous Complior SP and with Sphygmocor (AtCor, Australia), and to compare 
central systolic pressure from Complior Analyse and Sphygmocor. 
Peripheral and central pressure and PWV were measured with the 3 devices in 112 
subjects. PWV measurements from Complior Analyse were analyzed using two foot-
detection algorithms (PWVca_it and PWVca_cs). Both radial (ao-SBPscr) and carotid 
(car-SBPscr) approaches from Sphygmocor were compared to carotid Complior 
Analyse measurements (car-SBPca). Same distance and same calibrating pressures 
were used for all devices. 
PWVca_it was strongly correlated to PWVscr (R2=0.93, p<0.001) with a difference of 
0.0±0.7 m/s. PWVca_cs was also correlated to PWVcs (R2=0.90, p<0.001) with a 
difference of 0.1±0.7 m/s. Central systolic pressures were strongly correlated. The 
difference between car-SBPca and ao-SBPscr was 3.1±4.2mmHg (p<0.001), 
statistically equivalent to the difference between car-SBPscr and ao-SBPscr 
(3.9±5.8mmHg, p<0.001) while the difference between car-SBPca and car-SBPscr 
was negligible (-0.7±5.6 mmHg, p=ns). 
Conclusion: the new Complior Analyse device provides equivalent results for PWV 
and central pressure values than Sphygmocor and Complior SP. It reaches AAMI 
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standard for central BP and grades excellent for PWV on the Artery society criteria. It 
can be interchanged with existing devices.  
 
 
 
Abstract: 250 words 
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Short abstract  
The new Complior Analyse device allows simultaneous measurement of pulse wave 
velocity (PWV) and central pressure (cBP) during a single acquisition. This study 
compared PWV values obtained with the new Complior Analyse with the previous 
Complior SP device and to the Sphygmocor device for pulse wave velocity (PWV) 
values in 112 subjects with a wide range of PWV. It reaches “excellent” grade on the 
“Artery” society criteria for both comparison. In the same cohort, Complior Analyse 
cBP was compared to non-invasive cBP estimated with Sphygmocor. Complior 
Analyse reaches AAMI standard for systolic cBP. 
 
 
Short abstract: 93 words 
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Introduction: 
Aortic stiffness measured by carotid-femoral pulse wave velocity (PWV) has proven 
its clinical importance as an independent marker of cardiovascular risk and mortality 
in the general population[1-7] and in a variety of disease conditions including renal 
failure[8-14], diabetes [15], stroke[16-18] and hypertension[19-21]. Most of these 
epidemiological studies have be performed with the Complior device (Alam Medical, 
France) [1, 4, 5, 9, 12, 14, 18-20] as it provides rapid and reproducible assessment of 
PWV[22, 23]. Complior uses simultaneous carotid and femoral measurements as 
advised by the Artery Society [24]. Although widely used for PWV measurement, 
sensors used in the previous version were not enough responsive for performing 
pressure wave analysis. In this latest evolution, Complior Analyse (ca) is equipped 
with high quality pressure sensors which have been shown to record invasive signals 
accurately[25]. During standard PWV measurement, it is hence now possible to 
assess central pressure directly from carotid waveforms. Carotid pressure waveforms 
have been shown be quite similar to aortic pressure waves[26, 27] and 3 out of 6 
studies showing that central pressure better predicts cardiovascular mortality than 
peripheral pressure have been performed from carotidograms[28-30], 2 from invasive 
aortic waveforms[31, 32] and only 1 from estimated aortic waveforms[33]. 
The previous version of Complior has been validated regarding PWV values[22, 34, 
35]. Since then, the Artery society has produced guidelines and a protocol to validate 
non-invasive PWV devices[24]. However to date no standardised protocol exists to 
validate measurement of central pressure. As sensors and the algorithm to detect the 
foot of the waveform have been changed, the first aim of the present study was to 
estimate the ability of the Complior Analyse device to measure PWV following the 
protocol from the Artery society. The second objective was to compare central 
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systolic pressure values measured with Complior Analyse with non-invasive 
assessments of central pressure with the Sphygmocor CPV device (AtCor, Australia). 
 
Methods: 
112 subjects were recruited subsequently from the Artery Research Laboratory in 
European Hospital of George Pompidou. Measurements were performed part of 
clinical research studies or part of a routine arterial screening procedure including 
among other thing, central pressure, carotid-femoral PWV, carotid intima-media 
thickness and carotid wall characterization. All patients gave written informed 
consent.  
 
PWV study 
After 10 minutes of supine rest, peripheral blood pressure was measured every 3 min 
to check haemodynamic stability. Carotid femoral PWV was then measured 
alternatively by trained operators (FS et EB) in triplicate with the previous Complior 
SP device (PWVcs), with the Sphygmocor (PWVscr) and with the new Complior 
Analyse device (PWVca). Single recordings were deemed acceptable is the SD of 
the PWV recording was below 0.5m/s. Distance was assessed as 0.8 times the direct 
surface measurement between the carotid and femoral arterial sites as now 
recommended[36]. The same distance was used for the 3 devices.  
Both Complior SP and Sphygmocor were used as comparison devices. Indeed 
Complior SP was used in numerous epidemiological studies [1, 4, 5, 9, 12, 14, 18-
20]. It measured simultaneous distension waveforms sampled at 4kHz on 12bits and 
qualified as the recommended non-invasive reference for the Artery Society 
protocol[24]. However the foot of the waveforms is detected with a validated 
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proprietary algorithm based on the second derivative and auto-correlation[22]. This 
algorithm has been found to differ from the now recommend intersecting tangent 
algorithm especially for higher value of PWV[37].  
The Sphygmocor system (v8.2, AtCor, Australia) uses ECG-gated tonometric 
measurement sampled at 128 Hz on 12bits and the intersecting tangent algorithm. As 
such it only qualified as “secondary reference” in the Artery Society guidelines[24]. 
The new Complior Analyse system uses simultaneous pressure signals sampled at 1 
kHz on 16bits and allows both algorithms to be used. Complior Analyse PWV values 
with SP algorithm (PWVca_cs) was hence compared to Complior SP PWV values 
(PWVcs) while values from the Complior Analyse with the intersecting tangent 
algorithm (PWVca) were compared to Sphygmocor PWV values (PWVscr).  
 
 
Central pressure study 
Radial and carotid tonometry with Sphygmocor were performed to assess central 
pressure. Radial tonometry waveforms were calibrated to brachial cuff systolic and 
diastolic pressures performed immediately before and used to estimate aortic systolic 
pressure with the Sphygmocor’s generalized transfer function (ao-SBPscr). Carotid 
waveforms were calibrated to cuff diastolic pressure and mean pressure assessed 
from the area under the radial curve[38]. No transfer function was applied on the 
carotid waveforms and carotid systolic pressure was obtained from direct calibration 
of the carotid waveform (car-SBPscr) using mean and diastolic blood pressure. 
Carotid systolic pressure from Complior Analyse (car-SBPca) was obtained from 
carotid traces acquired during the PWV assessment. It has to be highlighted that ao-
SBPscr is an estimation of the aortic arch systolic pressure, while car-SBPscr and 
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car-SBPca are direct measures at the carotid level. While carotid and aortic pressure 
are usually both referred as central pressure, it is important to note that they are 
actually from different anatomical sites.  In order to compare accuracy of signal 
recordings, Complior Analyse and Carotid Sphygmocor traces were calibrated using 
the same brachial cuff diastolic and integrated mean radial pressures. All measures 
were done in triplicate. 
   
Statistics: 
For each subjects the average of the 3 recordings taken with each device was 
calculated. The coefficient of variation was calculated as averaged subject mean 
standard deviation (SD) divided by the subject mean value and expressed as a 
percentage. 
Scatter plot and Pearson’s correlation coefficient was used to check correlation 
between variables. Bland Altman plot were used to assess the amplitude of the 
difference and check the absence of trend across the value range. The accuracy 
criteria for PWV was taken from the Artery Society guidelines document[24]: 
PWV measurement were classified as “excellent” if the mean difference is below 
0.5m/s and the SD of the difference 0.8m/s and as “acceptable” if the mean 
difference <1.0 m/s and SD≤1.5m/s. 
The standard requirements for the non-invasive brachial BP monitors from the 
Association for the Advancement of Medical Instrumentation (AAMI)[39] was used to 
evaluate the goodness of agreement between central systolic pressure values: mean 
difference < 5mmHg and SD < 8mmHg. 
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Results:  
PWV validation 
3 subjects were discarded for PWV analysis for failure to obtain in triplicate with one 
of the 3 devices good quality carotid recordings which prevent correct foot detection 
(1 per device). 2 were further discarded because blood pressure and/or heart rate 
varied by more than 10mmHg or bpm between devices. 
Characteristics of the remaining 107 subjects are shown on table 1. 
Coefficient of variation for PWVscr values was 5.25%, 4% for PWVcs, 3.4% for 
PWVca with the intersecting tangent algorithm and 3.0 % for PWVca with the SP 
algorithm. 
As expected from the literature[37, 40], PWVscr and PWVcs were strongly correlated 
(R2=0.87, p<0.001) but they were different especially for higher value of PWV with 
Complior SP underestimating PWV compared to Sphygmocor as shown on figure 1 
(overall mean difference = -0.3 ± 0.9 m/s, p=ns). The accuracy between this 2 
devices reached “acceptable” on the Artery society guidelines[24]. 
PWVca with the intersecting tangent algorithm was strongly correlated with PWVscr 
(R2=0.93, p<0.001) with very little difference (error = 0.0 ± 0.7 m/s, p=ns) and no 
trend across the PWV range (see figure 2). This rated “excellent” on the accuracy 
criteria from the Artery society[24].  
PWVca with the SP algorithm was also strongly correlated with PWVcs (R2=0.90, 
p<0.001). The difference and its standard deviation between the previous and the 
latest version of Complior were 0.1 ± 0.8 m/s (p=ns) reaching the “excellent” grade 
(figure 3).   
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Central pressure comparison 
14 subjects were discarded due to inability to get good quality carotid recordings in 
triplicate with stable peripheral blood pressure: 9 with the Sphygmocor device, 6 with 
the Complior Analyse device, including 2 on both devices.  
Characteristics of the remaining 98 subjects are shown on table 1. Measurements of 
central systolic pressures from direct carotid traces with Sphygmocor (car-SBPscr) 
and Complior Analyse (car-SBPca) showed very strong correlation 
(R2=0.94,p<0.001, figure 4). The difference and its standard deviation was small and 
fulfilled the AAMI criteria (-0.7 ± 5.6 mmHg , p=ns). 
When compared to aortic pressure estimated from radial waveforms with 
Sphygmocor (ao-SBPscr), car-SBPca was also strongly correlated (R2=0.96, 
p<0.001, figure 5) but the Bland-Altman analysis showed a small significant 
difference between the two anatomically different sites (error=3.1 ± 4.2 mmHg, 
p<0.001, figure 5). This difference was of the same magnitude than the one observed 
between carotid and estimated aortic from Sphygmocor (R2=0.96,p<0.001, error = 
3.7 ± 5.5, p<0.001, figure 6). However they both still fulfill the AAMI criteria. 
 
 
 
Discussion: 
 
This study showed that the new Complior Analyse device provides similar PWV 
results than the Sphygmocor CPV device or than the previous Complior SP device 
when a matching algorithm is used. Central pressure measurement from the carotid 
with Complior Analyse was also comparable to non-invasive Sphygmocor estimates. 
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The Complior SP device was used in most epidemiological studies [1, 4, 5, 9, 12, 14, 
18-20]. It has been validated in the past when the recommended foot detection 
algorithm was not the intersecting tangent[22, 34, 35]. Our results confirm that the 
new Complior Analyse system is substitutable to older versions of Complior SP when 
using the same algorithm. 
PWV can be assessed with simultaneous measurement as with Complior or 
alternatively, successive ECG gated acquisitions can be performed. These 2 
approaches have been found equivalent when hemodynamic state is stable[41]. 
However our results showed that the coefficient of variation for repeated measures 
was slightly higher with ECG gated measurements (CV = 5.25 % for PWVscr) than 
with simultaneous measurements (CV = 3.4 %  for PWVca with intersecting tangent 
algorithm) even in highly controlled conditions where blood pressure and heart rate 
were very stable.  
Several algorithms have been proposed to detect the foot of the waveform[22, 42, 
43]. They are unfortunately not equivalent especially regarding higher values of PWV 
[37, 43, 44]. However, as it is less sensitive to measurements artefact and shows the 
least variability[42], the Artery Society[24] and the Expert consensus on arterial 
stiffness[36] recommend to use the “intersecting tangent” algorithm. This algorithm is 
now implemented in the latest version of the Complior system and shows quasi 
perfect agreement with the Sphygmocor v8.2 device with no trend across PWV range 
(right panel, figure 2). A recent publication [45] comparing carotid to leg cuff approach 
to Sphygmocor CPV showed an overall small difference with however much higher 
discrepancy for higher value and  of PWV questioning its applicability in higher risk 
patients. 
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After foot-detection algorithm, the second parameter influencing greatly PWV is the 
arterial distance. Because our aim was to compare techniques, we chose to use the 
same distance for each device. Indeed, when comparing two techniques, the use of 
the correct distance is less important than using identical distance values for the 3 
devices. Using a different distance methodology (caliper instead of tape meter for 
example) would only have modified absolute values of PWV. Similar results are 
obtained by comparing directly transit time. It would not change our conclusion that 
Complior Analyse PWV measure reaches “excellent” on the Artery Society criteria. 
As recommended, our study population had a large range of age and blood pressure, 
however only 25% of the study group have an elevated PWV value (>10m/s). Hence 
our results might not be generalised to a population of patients with very stiff arteries.  
With its new pressure sensors, Complior Analyse now records carotid pressure 
waveforms during the standard PWV measurement.  
The accuracy to correctly monitor invasive pressure traces has been published 
elsewhere with good agreement between harmonics content of invasive and 
Complior Analyse waveform[25]. Sphygmocor tonometer also showed similar 
frequency content than invasive waveforms[46]. The quality of central pressure 
assessment relies on the fidelity of recording of the pressure wave, coupled with 
adequate calibration. Because of increased capacity of AD converters, compared to 
SphygmoCor, Complior Analyse allows a 8x increase in time resolution and improved 
dynamics by 10 dB, which might contribute to the good performance of this device. 
Both Complior Analyse and SphygmoCor devices use applanation tonometry which 
provides uncalibrated waveforms whose amplitude and offset depends on the hold-
on pressure, on the underlying tissue characteristics and on intra-arterial pressure. 
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Our results here show that provided similar calibration, Complior Analyse gives 
similar central systolic pressure than Sphygmocor. The Sphygmocor device has been 
extensively validated and shows good agreement with invasive pressure when 
invasively calibrated[47].  
We have shown that there is an excellent agreement between SphygmoCor and 
Complior Analysis devices in term of waveform analysis and we obtained values of 
central pressure that are practically similar. Thus both device are interchangeable.  
Our results also highlight the presence of a small difference between aortic and 
carotid systolic pressure which is expected on physiological grounds. While carotid 
and ascending arteries are geographically and functionally very close, the 10-15 cm 
difference between the 2 sites might explain amplification by 3mmHg between carotid 
and aortic pressures. Invasive studies comparing carotid and aortic waveforms did 
not focus on central systolic pressure[26, 27], however Salvi et al.[41] reported a 
difference of 2.5mmHg between the 2 sites which is comparable to our results. In 
their paper comparing invasive pressures with carotid distension waveforms, Van 
Bortel et al. also found similar difference (3.8 mmHg)[38]. This difference is small and 
falls well within the AAMI criteria. It does not invalidate mortality studies showing that 
central pressure is a stronger predictor of cardiovascular events and mortality than 
peripheral pressure[28-30]. Despite that the carotid approach is the one the most 
used in mortality studies, it has to been mentioned that good quality carotid 
waveforms can be difficult to obtain with tonometry. Indeed, the absence of 
underlying bony structure, the presence of the soft tissues and the proximity of the 
trachea can make the measurement difficult as shown by the fact we had to discard 
10% (14 out of our 112) of the subjects due to inability to perform measurements 
triplicate with both device. Here we were able to use the ‘real’ mean blood pressure 
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by integrating radial blood pressure. Because there are small but quantifiable 
differences between brachial and radial pressure waveforms form factors, and 
because applanation of radial artery might not be routinely performed with Complior 
Analyse, the use of calculated mean arterial pressure might induce larger 
discrepancies with alternative methods. 
The new Complior Analyse system is equivalent to Complior SP or Sphygmocor 
devices when the appropriate algorithm is used and it grades “excellent” on the 
Artery society criteria. Carotid-femoral PWV is a recommended parameter to assess 
organ damage and cardiovascular risk in the management of arterial 
hypertension[48]. Our results show that the medical device industry is actively 
working to provide accurate and reliable systems to the market. This will surely 
contribute to the expansion of the measurement of arterial stiffness in routine patient 
risk assessment.  
Complior Analyse new pressure sensor with appropriate calibration allows to 
measure accurately central systolic pressure directly from the carotid with no 
assumption or mathematical modelling. It could hence be used in research studies 
and clinical routine especially in subjects when the application of a transfer function is 
questionable such as children or patients with upper arm arterial calcification. 
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Table 1: Patients characteristics 
 
 mean ±  sd range 
PWV validation n=107 (55 men – 52 women) 
Age (yrs) 47.2 ± 15.7 16 - 83 
BMI (kg/m2) 24.5 ± 4.2 17.4 - 35.4 
SBP (mmHg) 128 ± 51 91 - 224 
DBP (mmHg) 70 ± 11 46 - 108 
HR (bpm) 66 ± 10 45 - 95 
PWV Sphygmocor 8.6 ± 2.5 5.1 – 19.9 
PWV Complior SP 8.2 ± 2.1 4.9 – 17.6 
PWV Complior Analyse intersecting 
tangents algorithm 
8.6 ± 2.6 5.3 – 19.4 
PWV Complior analyse peak of second 
derivative algorithm 
8.3 ± 2.4 5.2 – 18.3 
   
Central Pressure validation n=98 (49 men and 49 women) 
Age (yrs) 47.4 ± 15.4 18 – 83 
BMI (kg/m2) 24.6 ± 4.2 17.6 – 35.4 
Peripheral SBP (mmHg) 131 ± 20 100 - 236 
Peripheral DBP (mmHg) 73 ± 11 53 – 116 
Peripheral MBP (mmHg) 92 ± 15 67 – 163 
HR (bpm) 66 ± 10 44 – 94  
Aortic SBP (Sphygmocor, transfer 
function) 
117 ± 21 84 – 220  
Carotid SBP (Sphygmocor) 121 ± 24 83 – 246 
Carotid SBP (Complior Analyse) 120 ± 22 88 – 232 
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Figure 1: 
Comparison of pulse wave velocity values from Sphygmocor device (PWVscr) and the Complior SP device (PWVcs). 
Left: Scatter plot with regression line (solid line). The dotted line represents the identity line. 
Right: Bland-Altman plot of the difference.  
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Figure 2: 
Comparison of pulse wave velocity values from Sphygmocor device (PWVscr) and the new Complior Analyse device with the 
intersecting tangent algorithm (PWVca_it). 
Left: Scatter plot with regression line (solid line). The identity line is superimposed with the regression line and hence not visible. 
Right: Bland-Altman plot of the difference.  
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Figure 3: 
Comparison of pulse wave velocity values from Complior SP device (PWVcs) and the new Complior Analyse device with the SP 
algorithm (PWVca_cs). 
Left: Scatter plot with regression line (solid line). The dotted line represents the identity line. 
Right: Bland-Altman plot of the difference.  
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Figure 4: 
Comparison of central systolic pressure measured from Sphygmocor carotid traces (car-SBPscr) and Complior Analyse carotid 
traces (car-SBPca) 
Left: scatter plot with regression line (solid line) 
Right: bland-Altman plot of the difference 
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Figure 5 
Comparison of central systolic pressure estimated from Sphygmocor radial traces (ao-SBPscr) and Complior Analyse carotid traces 
(car-SBPca) 
Left: scatter plot with regression line (solid line) 
Right: bland-Altman plot of the difference 
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Figure 6 
Comparison of central systolic pressure measured from Sphygmocor carotid traces (car-SBPscr) and estimated from Sphygmocor 
radial traces (ao-SBPscr) 
Left: scatter plot with regression line (solid line) 
Right: bland-Altman plot of the difference 
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